BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38067360)

  • 1. Potential of Fecal Carcinoembryonic Antigen for Noninvasive Detection of Colorectal Cancer: A Systematic Review.
    Li X; Stassen L; Schrotz-King P; Zhao Z; Cardoso R; Raut JR; Bhardwaj M; Brenner H
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage.
    Li L; Xing S; Wu M; Ao Y; Zheng X; Cai R; Han R; Li J; Li X; Zeng Q
    Cancer Control; 2021; 28():10732748211048292. PubMed ID: 34615391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of fecal carcinoembryonic antigen as diagnosis marker for adenomatous polyposis coli and asymptomatic colorectal cancer.
    Li L; Gu W; Wu X; Ao Y; Song Y; Li X; Zeng Q
    Therap Adv Gastroenterol; 2021; 14():17562848211062792. PubMed ID: 34987605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating CEA-IgM complexes in early stage colorectal cancer.
    Castaldi F; Marino M; Beneduce L; Belluco C; De Marchi F; Mammano E; Nitti D; Lise M; Fassina G
    Int J Biol Markers; 2005; 20(4):204-8. PubMed ID: 16398401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review.
    Raut JR; Guan Z; Schrotz-King P; Brenner H
    Clin Epigenetics; 2020 Aug; 12(1):122. PubMed ID: 32778176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of carcinoembryonic antigen detection in the early diagnosis of colorectal cancer: A systematic review and meta-analysis.
    Wang R; Wang Q; Li P
    World J Gastrointest Surg; 2023 Dec; 15(12):2907-2918. PubMed ID: 38222002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stool
    Zhan Y; Wang S; Yuan Z; Zhao X; Ni K; Xin R; Zhou X; Liu Z; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Zhang X; Zhang Q; Liu Y; Zhang C
    Transl Cancer Res; 2023 Jan; 12(1):65-77. PubMed ID: 36760372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive diagnostic tests for Helicobacter pylori infection.
    Best LM; Takwoingi Y; Siddique S; Selladurai A; Gandhi A; Low B; Yaghoobi M; Gurusamy KS
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012080. PubMed ID: 29543326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19-9, gender, and age.
    Zhao R; Xia D; Chen Y; Kai Z; Ruan F; Xia C; Gong J; Wu J; Wang X
    Cancer Med; 2023 Jul; 12(13):14636-14645. PubMed ID: 37162269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
    Meklin J; SyrjÄnen K; Eskelinen M
    Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer.
    Wang QQ; Zhou L; Qin G; Tan C; Zhou YC; Yao SK
    World J Gastroenterol; 2023 Oct; 29(37):5313-5326. PubMed ID: 37899785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
    Huang X; Lan Y; Li E; Li J; Deng Q; Deng X
    J Int Med Res; 2021 May; 49(5):3000605211012570. PubMed ID: 33942633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta-analysis.
    Zhang X; Zhu X; Cao Y; Fang JY; Hong J; Chen H
    Cancer Med; 2019 Feb; 8(2):480-491. PubMed ID: 30636375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microRNAs, Fecal microRNA Panels, or Combinations of Fecal microRNAs with Fecal Hemoglobin for Early Detection of Colorectal Cancer and Its Precursors: A Systematic Review.
    Zhao Z; Zhu A; Bhardwaj M; Schrotz-King P; Brenner H
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008229
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.